Showing results (1051-1060 of 9,901) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|January 1, 1992
Clinical and biological aspects of human umbilical cord blood as a source of transplantable hematopoietic stem and progenitor cellsH E Broxmeyer, G Hangoc, S Cooper
Bone Marrow Transplantation|December 23, 2003
Pulmonary function after autologous bone marrow transplantation in children: a long-term prospective studyP Frisk, J Arvidson, L-E Bratteby, et al.
Bone Marrow Transplantation|January 20, 2004
Long-term follow-up of patients with poor prognosis germ cell tumor treated with early high-dose chemotherapy with hematopoietic progenitor cell support: a single-center experienceU De Giorgi, G Rosti, G Papiani, et al.
Bone Marrow Transplantation|January 20, 2004
Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphomaA Martín, J-A Pérez-Simón, M D Caballero, et al.
Bone Marrow Transplantation|January 20, 2004
An unexpectedly high incidence of Epstein-Barr virus lymphoproliferative disease after CD34+ selected autologous peripheral blood stem cell transplant in neuroblastomaJ L Powell, N J Bunin, C Callahan, et al.
Bone Marrow Transplantation|January 20, 2004
Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantationM Ortega, M Rovira, M Almela, et al.
Bone Marrow Transplantation|January 6, 2004
Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseasesP Lang, T Klingebiel, P Bader, et al.
Bone Marrow Transplantation|January 6, 2004
Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipientsN L Lewis, M Mullaney, K F Mangan, et al.
Bone Marrow Transplantation|October 17, 2003
Differences between graft product and donor side effects following bone marrow or stem cell donationG Favre, M Beksaç, A Bacigalupo, et al.
Bone Marrow Transplantation|October 17, 2003
Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysisD L Forrest, T J Nevill, S C Naiman, et al.
Pageof 991